1-8 of 8
William A. Robinson
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

An Updated Analysis on Safety and Efficacy of Avapritinib in Patients with Advanced Systemic Mastocytosis from the Explorer Clinical Study: Long-Term Efficacy and Safety

Daniel J. DeAngelo, Deepti H. Radia, Tracy I. George, William A. Robinson, Albert T. Quiery, Mark W. Drummond, Prithviraj Bose, Elizabeth O. Hexner, Elliott Winton, Hans-Peter Horny, Meera Tugnait, Hui-Min Lin, Saša Dimitrijević, Javier I. Munoz-Gonzalez, Ilda Bidollari, Michael W. Deininger, Jason Gotlib
Journal: Blood
Blood (2022) 140 (Supplement 1): 3932–3934.
https://doi.org/10.1182/blood-2022-167593
Published: 2022
Journal Articles

Pure Pathologic Response Is Associated with Improved Overall Survival in Patients with Advanced Systemic Mastocytosis Receiving Avapritinib in the Phase I EXPLORER Study

Jason Gotlib, MD MS, Deepti H. Radia, MRCPI, FRCPath, Tracy I. George, MD, William A Robinson, MD PhD, Albert T. Quiery, MD, Mark W. Drummond, PhD FRCPath, Prithviraj Bose, MD, Elizabeth O. Hexner, MD, Elliott F. Winton, MD, Hans-Peter Horny, Prof, Dr, Meera Tugnait, PhD, Oleg Schmidt-Kittler, PhD, Erica K. Evans, PhD, Hui-Min Lin, PhD, Brenton G. Mar, MD PhD, Michael W. Deininger, MD PhD, Daniel J. DeAngelo, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 37–38.
https://doi.org/10.1182/blood-2020-137413
Published: 2020
Journal Articles

Avapritinib, a Potent and Selective Inhibitor of KIT D816V, Improves Symptoms of Advanced Systemic Mastocytosis (AdvSM): Analyses of Patient Reported Outcomes (PROs) from the Phase 1 (EXPLORER) Study Using the (AdvSM) Symptom Assessment Form (AdvSM-SAF), a New PRO Questionnaire for (AdvSM)

Jason R. Gotlib, MDMS, Deepti Radia, MD, Daniel J. DeAngelo, MD, Prithviraj Bose, MD, Mark W Drummond, PhDMD, Elizabeth O. Hexner, MDMS, William A Robinson, MD PhD, Maureen G. Conlan, MD, Ronny G. Oren, MS, Hongliang Shi, Michael W. Deininger, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 351.
https://doi.org/10.1182/blood-2018-99-112017
Published: 2018
Journal Articles

Clinical Activity in a Phase 1 Study of Blu-285, a Potent, Highly-Selective Inhibitor of KIT D816V in Advanced Systemic Mastocytosis (AdvSM)

Daniel J. DeAngelo, MD, Albert Thomas Quiery, MD, Deepti Radia, MD, Mark W Drummond, MB ChB, PhD FRCPath, Jason Gotlib, MD, William A Robinson, MD PhD, Elizabeth Hexner, MDMS, Srdan Verstovsek, MD PhD, Hongliang Shi, Terri Alvarez-Diez, Oleg Schmidt-Kittler, Erica Evans, PhD, Mary Ellen Healy, Beni B. Wolf, MD PhD, Michael W. Deininger, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2.
https://doi.org/10.1182/blood.V130.Suppl_1.2.2
Published: 2017
Journal Articles

Truncation in CCND1 mRNA alters miR-16-1 regulation in mantle cell lymphoma

Robert W. Chen, Lynne T. Bemis, Carol M. Amato, Han Myint, Hung Tran, Diane K. Birks, S. Gail Eckhardt, William A. Robinson
Journal: Blood
Blood (2008) 112 (3): 822–829.
https://doi.org/10.1182/blood-2008-03-142182
Published: 2008
Journal Articles

Cyclic Leukocytosis in Chronic Myelogenous Leukemia: New Perspectives on Pathogenesis and Therapy

Richard A. Gatti, M.D., William A. Robinson, M.D., Ph.D., Amos S. Deinard, M.D., Mark Nesbit, M.D., Jeffrey J. McCullough, M.D., Mark Ballow, M.D., Robert A. Good, M.D., Ph.D.
Journal: Blood
Blood (1973) 41 (6): 771–782.
https://doi.org/10.1182/blood.V41.6.771.771
Published: 1973
Journal Articles

Colony Growth of Human Leukemic Peripheral Blood Cells In Vitro

WILLIAM A. ROBINSON, M.D., PH.D., JOHN E. KURNICK, Major, M.D., M.C., BEVERLEY L. PIKE, A.A.I.M.L.T.
Journal: Blood
Blood (1971) 38 (4): 500–508.
https://doi.org/10.1182/blood.V38.4.500.500
Published: 1971
Journal Articles

Colony Growth of Human Peripheral White Blood Cells In Vitro

JOHN E. KURNICK, M.D., WILLIAM A. ROBINSON, M.D., PH.D.
Journal: Blood
Blood (1971) 37 (2): 136–141.
https://doi.org/10.1182/blood.V37.2.136.136
Published: 1971